Christopher P. Tostado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christopher P. Tostado has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Carlo Miccolis
Genome Institute of Singapore, Laboratory of Precision Oncology and Cancer Evolution Singapore Singapore
1 shared publication- Jia Wei Joel Heng
Genome Institute of Singapore, Laboratory of Precision Oncology and Cancer Evolution Singapore Singapore
1 shared publication Justine Jia Wen Seow
Genome Institute of Singapore, Laboratory of Precision Oncology and Cancer Evolution Singapore Singapore
1 shared publicationLucas Xian Da Ong
Institute for Health Innovation and Technology (iHealthtech), National University of Singapore Singapore Singapore
1 shared publication- Ramanuj DasGupta
Laboratory of Tumour Evolution, University of Glasgow, Glasgow, UK
1 shared publication Shumei Chia
Genome Institute of Singapore, Laboratory of Precision Oncology and Cancer Evolution Singapore Singapore
1 shared publication
Latest Publications
- Open Access
- 2 January 2024
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 9 (2) , e10628
An AI‐assisted integrated, scalable, single‐cell phenomic‐transcriptomic platform to elucidate intratumor heterogeneity against immune response
We present a novel framework combining single‐cell phenotypic data with single‐cell transcriptomic analysis to identify factors underpinning heterogeneity in antitumor immune response. We developed a pairwise, tumor‐immune discretized interaction assay between natural killer (NK‐92MI) cells and patient‐derived head and neck squamous cell carcinoma (HNSCC) cell lines on a microfluidic cell‐trapping platform. Furthermore we generated a deep‐learning computer vision algorithm that is capable of automating the acquisition and analysis of a large, live‐cell imaging data set (>1 million) of paired tumor‐immune interactions spanning a time course of 24 h across multiple HNSCC lines (n = 10). Finally, we combined the response data measured by Kaplan–Meier survival analysis against NK‐mediated killing with downstream single‐cell transcriptomic analysis to interrogate molecular signatures associated with NK‐effector response. As proof‐of‐concept for the proposed framework, we efficiently identified MHC class I‐driven cytotoxic resistance as a key mechanism for immune evasion in nonresponders, while enhanced expression of cell adhesion molecules was found to be correlated with sensitivity against NK‐mediated cytotoxicity. We conclude that this integrated, data‐driven phenotypic approach holds tremendous promise in advancing the rapid identification of new mechanisms and therapeutic targets related to immune evasion and response.
- 2 January 2024
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 9 (2) , e10628
Open AccessAn AI‐assisted integrated, scalable, single‐cell phenomic‐transcriptomic platform to elucidate intratumor heterogeneity against immune response
We present a novel framework combining single‐cell phenotypic data with single‐cell transcriptomic analysis to identify factors underpinning heterogeneity in antitumor immune response. We developed a pairwise, tumor‐immune discretized interaction assay between natural killer (NK‐92MI) cells and patient‐derived head and neck squamous cell carcinoma (HNSCC) cell lines on a microfluidic cell‐trapping platform. Furthermore we generated a deep‐learning computer vision algorithm that is capable of automating the acquisition and analysis of a large, live‐cell imaging data set (>1 million) of paired tumor‐immune interactions spanning a time course of 24 h across multiple HNSCC lines (n = 10). Finally, we combined the response data measured by Kaplan–Meier survival analysis against NK‐mediated killing with downstream single‐cell transcriptomic analysis to interrogate molecular signatures associated with NK‐effector response. As proof‐of‐concept for the proposed framework, we efficiently identified MHC class I‐driven cytotoxic resistance as a key mechanism for immune evasion in nonresponders, while enhanced expression of cell adhesion molecules was found to be correlated with sensitivity against NK‐mediated cytotoxicity. We conclude that this integrated, data‐driven phenotypic approach holds tremendous promise in advancing the rapid identification of new mechanisms and therapeutic targets related to immune evasion and response.